The present invention is further based, in part, on the discovery that L1CAM inhibition inhibited the growth of chemoresistant lung cancer xenografts, supporting a mechanism of action distinct from cytotoxic drugs, and that inhibition of L1CAM was observed to render chemoresistant tumor cells …
Treatment of metastatic cancer and model systems for metastatic disease
